Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Talis Biomedical Corporation Common Stock
TLIS | US
1.69
USD-0.16
-8.65%
TLIS | US
About Talis Biomedical Corporation Common Stock
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
21/10/2024
Close
1.69
Open
1.70
High
1.70
Low
1.69
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also develops Talis One tests for respiratory infections infections related to women's health and sexually transmitted infections; and other tests for the detection of other respiratory infections such as a respiratory panel test to detect influenza A and influenza B. The company was incorporated in 2013 and is headquartered in Redwood California.
View LessTLIS | US
Risk
78.3
Sharpe
-0.69
Luna's Score
31/100
Recommendation
Sell
Luna says (TLIS | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
77.2%1 month
78.3%3 months
197.4%6 months
134.9%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.07
Debt to equity
0.39
Debt to assets
0.26
Ent. to EBITDA
0.86
Ent. to rev.
14.57
PEG
-
Other Fundamentals
EBITDA
-45.58M
MarketCap
2.81M
MarketCap(USD)
2.81M
Div. yield
-
Op. margin
-11.36K
Erngs. growth
-
Rev. growth
-94.00
Ret. on equity
-70.48
Short ratio
0.59
Short perc.
1.54
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.21
Range1M
0.54
Range3M
9.35
Volumes: Market Activity
Rel. volume
1.61
Price X volume
16.29K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.86 | 46.09 | Cheaper |
| Ent. to Revenue | 14.57 | 14.34 | Par |
| PE Ratio | - | 30.41 | - |
| Price to Book | 0.07 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 197.37 | 64.12 | Riskier |
| Debt to Equity | 0.39 | -145.53 | Expensive |
| Debt to Assets | 0.26 | 0.35 | Cheaper |
| Market Cap | 2.81M | 9.70B | Emerging |
